Sutro Biopharma (STRO) Cash from Operations Growth (1y) (2018 - 2025)
Powered by 
Analysis
Sutro Biopharma (STRO) Cash from Operations Growth (1y) (2018 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 42.76% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 75.58% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 151.70% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 100.14% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 56.79% |
| 10 | Sutro Biopharma | 334.33 Mn | 169.99 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 63.15% |
| Sep 30, 2025 | 40.81% |
| Jun 30, 2025 | -573.02% |
| Mar 31, 2025 | -4.85% |
| Dec 31, 2024 | -609.79% |
| Sep 30, 2024 | -92.57% |
| Jun 30, 2024 | 130.31% |
| Mar 31, 2024 | -6.15% |
| Dec 31, 2023 | 158.97% |
| Sep 30, 2023 | -150.87% |
| Jun 30, 2023 | -879.13% |
| Mar 31, 2023 | -73.00% |
| Dec 31, 2022 | -10.58% |
| Sep 30, 2022 | 369.83% |
| Jun 30, 2022 | 39.46% |
| Mar 31, 2022 | -15.86% |
| Dec 31, 2021 | -14.31% |
| Sep 30, 2021 | -37.97% |
| Jun 30, 2021 | 57.90% |
| Mar 31, 2021 | -62.43% |